Trial Search Results
Exercise in Genetic Cardiovascular Conditions
The goal is to determine how lifestyle and exercise impact the well-being of individuals with hypertrophic cardiomyopathy (HCM) and long QT syndrome (LQTS).
Stanford is currently accepting patients for this trial.
Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Individuals with Hypertrophic Cardiomyopathy or Long QT Syndrome
- Individuals with Hypertrophic Cardiomyopathy with systolic or diastolic heart failure
which precludes vigorous exercise will not be enrolled (NYHA III/IV)
Ages Eligible for Study
8 Years - 60 Years
Genders Eligible for Study